Tandem Diabetes Care Inc (TNDM)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	489,574	425,414	390,514	379,455	367,690	389,918	404,590	404,801	412,987	411,193	403,513	394,021	376,215	353,042	321,610	283,546	260,520	230,236	215,606	211,120
Revenue (ttm)	US$ in thousands	1,059,521	973,669	796,002	770,009	747,718	771,424	790,349	794,694	801,218	790,712	765,792	737,669	702,799	660,868	604,844	541,941	498,830	439,163	410,217	394,236
Gross profit margin		46.21%	43.69%	49.06%	49.28%	49.17%	50.55%	51.19%	50.94%	51.54%	52.00%	52.69%	53.41%	53.53%	53.42%	53.17%	52.32%	52.23%	52.43%	52.56%	53.55%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $489,574K ÷ $1,059,521K
= 46.21%

Tandem Diabetes Care Inc's gross profit margin has shown fluctuations over the quarters provided in the data. It started at a relatively high level of 53.55% in March 2020 and remained above 52% until June 2022, peaking at 53.53% in December 2021. However, from March 2023, there was a noticeable decline in the gross profit margin, dropping to 49.17% by the end of December 2023.

The trend continued in 2024, with the gross profit margin further decreasing to 43.69% by September 2024 before slightly recovering to 46.21% by the end of the year. This decline in the gross profit margin could indicate challenges in managing production costs or pricing pressures during this period for Tandem Diabetes Care Inc.

It would be essential for the company to closely monitor its cost structure and pricing strategies to potentially improve its gross profit margin performance and overall financial health in the future.